2-tert-butylhydroquinone has been researched along with sirolimus in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Auld, DS; Austin, CP; Huang, R; Moeller, TA; Sakamuru, S; Shinn, P; Shukla, SJ; Vanleer, D; Xia, M | 1 |
Bartke, A; Miller, RA; Steinbaugh, MJ; Sun, LY | 1 |
2 other study(ies) available for 2-tert-butylhydroquinone and sirolimus
Article | Year |
---|---|
Identification of clinically used drugs that activate pregnane X receptors.
Topics: Animals; Cell Line, Tumor; Cytochrome P-450 CYP3A; Drug Interactions; Hep G2 Cells; Hepatocytes; Humans; Pharmaceutical Preparations; Pregnane X Receptor; Rats; Receptors, Steroid; Small Molecule Libraries; Species Specificity; Structure-Activity Relationship; Xenobiotics | 2011 |
Activation of genes involved in xenobiotic metabolism is a shared signature of mouse models with extended lifespan.
Topics: Animals; Antioxidants; Caloric Restriction; Cytochrome P-450 Enzyme System; Female; Flavins; Gene Expression Regulation; Hydroquinones; Liver; Longevity; Male; Metallothionein; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Mixed Function Oxygenases; Oxidoreductases; Sirolimus; Up-Regulation; Xenobiotics | 2012 |